These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12091339)

  • 1. Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions.
    Reddy VA; Iwama A; Iotzova G; Schulz M; Elsasser A; Vangala RK; Tenen DG; Hiddemann W; Behre G
    Blood; 2002 Jul; 100(2):483-90. PubMed ID: 12091339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.
    Yeamans C; Wang D; Paz-Priel I; Torbett BE; Tenen DG; Friedman AD
    Blood; 2007 Nov; 110(9):3136-42. PubMed ID: 17671233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C/EBPalpha induces PU.1 and interacts with AP-1 and NF-kappaB to regulate myeloid development.
    Friedman AD
    Blood Cells Mol Dis; 2007; 39(3):340-3. PubMed ID: 17669672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C/EBPalpha bypasses granulocyte colony-stimulating factor signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts.
    Wang X; Scott E; Sawyers CL; Friedman AD
    Blood; 1999 Jul; 94(2):560-71. PubMed ID: 10397723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitment.
    Rangatia J; Vangala RK; Treiber N; Zhang P; Radomska H; Tenen DG; Hiddemann W; Behre G
    Mol Cell Biol; 2002 Dec; 22(24):8681-94. PubMed ID: 12446786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
    Guo H; Cooper S; Friedman AD
    PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between regulators of myeloid development: C/EBPalpha binds and activates the promoter of the PU.1 gene.
    Kummalue T; Friedman AD
    J Leukoc Biol; 2003 Sep; 74(3):464-70. PubMed ID: 12949251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
    Cooper S; Guo H; Friedman AD
    PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha.
    Friedman AD; Keefer JR; Kummalue T; Liu H; Wang QF; Cleaves R
    Blood Cells Mol Dis; 2003; 31(3):338-41. PubMed ID: 14636649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C/EBPalpha directs monocytic commitment of primary myeloid progenitors.
    Wang D; D'Costa J; Civin CI; Friedman AD
    Blood; 2006 Aug; 108(4):1223-9. PubMed ID: 16645168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C/EBP alpha:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBP alpha homodimers or AP-1.
    Cai DH; Wang D; Keefer J; Yeamans C; Hensley K; Friedman AD
    Oncogene; 2008 Apr; 27(19):2772-9. PubMed ID: 18026136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor.
    Wang QF; Friedman AD
    Blood; 2002 Apr; 99(8):2776-85. PubMed ID: 11929766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.
    Dahl R; Simon MC
    Blood Cells Mol Dis; 2003; 31(2):229-33. PubMed ID: 12972030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dominant-negative mutant of C/EBPalpha, associated with acute myeloid leukemias, inhibits differentiation of myeloid and erythroid progenitors of man but not mouse.
    Schwieger M; Löhler J; Fischer M; Herwig U; Tenen DG; Stocking C
    Blood; 2004 Apr; 103(7):2744-52. PubMed ID: 14656889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.
    Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B
    Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction.
    Dahl R; Iyer SR; Owens KS; Cuylear DD; Simon MC
    J Biol Chem; 2007 Mar; 282(9):6473-83. PubMed ID: 17197705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factors that regulate growth and differentiation of myeloid cells.
    Nagamura-Inoue T; Tamura T; Ozato K
    Int Rev Immunol; 2001 Feb; 20(1):83-105. PubMed ID: 11342299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional control of granulocyte and monocyte development.
    Friedman AD
    Oncogene; 2007 Oct; 26(47):6816-28. PubMed ID: 17934488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of CCAAT/enhancer-binding protein alpha or PU.1 in hematopoietic stem cells leads to their reduced self-renewal and proliferation.
    Fukuchi Y; Ito M; Shibata F; Kitamura T; Nakajima H
    Stem Cells; 2008 Dec; 26(12):3172-81. PubMed ID: 18787208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1.
    Petrovick MS; Hiebert SW; Friedman AD; Hetherington CJ; Tenen DG; Zhang DE
    Mol Cell Biol; 1998 Jul; 18(7):3915-25. PubMed ID: 9632776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.